Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
Scientists at the Dana-Farber Cancer Institute and elsewhere developed the vaccine, which is designed to prevent advanced cases of kidney cancer from returning. Since the trial patients received the vaccine roughly three years ago,